Showing results (31-40 of 41) with videos related to
Sort By:
Pageof 5
Neurology|January 2, 2024
Safety and Efficacy of Nipocalimab in Patients With Generalized Myasthenia Gravis: Results From the Randomized Phase 2 Vivacity-MG StudyCarlo Antozzi, Jeffrey Guptill, Vera Bril, et al.Brain : a Journal of Neurology|March 22, 2023
Neuropathy due to bi-allelic SH3TC2 variants: genotype-phenotype correlation and natural historyTyler Rehbein, Tong Tong Wu, Simona Treidler, et al.The Lancet. Neurology|January 25, 2025
Safety and efficacy of nipocalimab in adults with generalised myasthenia gravis (Vivacity-MG3): a phase 3, randomised, double-blind, placebo-controlled studyCarlo Antozzi, Tuan Vu, Sindhu Ramchandren, et al.Human Vaccines & Immunotherapeutics|May 5, 2026
Effect of nipocalimab on IgG responses to vaccinations and viral infections in patients with IgG autoantibody-mediated diseases: Post hoc analyses of three randomized, placebo-controlled trialsFaye Yu, Eugene Myshkin, Brandon Nguyen, et al.Journal of Neurology, Neurosurgery, and Psychiatry|February 10, 2022
Clinical practice guideline for the management of paediatric Charcot-Marie-Tooth diseaseEppie M Yiu, Paula Bray, Jonathan Baets, et al.Brain : a Journal of Neurology|August 28, 2015
Genotype-phenotype characteristics and baseline natural history of heritable neuropathies caused by mutations in the MPZ geneOranee Sanmaneechai, Shawna Feely, Steven S Scherer, et al.Annals of Neurology|October 7, 2022
Disease Progression in Charcot-Marie-Tooth Disease Related to MPZ Mutations: A Longitudinal StudyVera Fridman, Stefan Sillau, Jacob Bockhorst, et al.Brain : a Journal of Neurology|June 7, 2023
Genetic analysis and natural history of Charcot-Marie-Tooth disease CMTX1 due to GJB1 variantsChristopher J Record, Mariola Skorupinska, Matilde Laura, et al.Brain : a Journal of Neurology|January 8, 2021
Natural history of Charcot-Marie-Tooth disease type 2A: a large international multicentre studyMenelaos Pipis, Shawna M E Feely, James M Polke, et al.Neurology|February 13, 2020
A longitudinal study of CMT1A using Rasch analysis based CMT neuropathy and examination scoresVera Fridman, Stefan Sillau, Gyula Acsadi, et al.Pageof 5